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Abstract 15 
Food-producing animals throughout the world are likely to be exposed to antimicrobial 16 
(AM) treatment. The crossover in AM use between human and veterinary medicine 17 
raises concerns that antimicrobial resistance (AMR) may spread from food-producing 18 
animals to humans, driving the need for further understanding of how AMs are used in 19 
livestock practice as well as stakeholder beliefs relating to their use. A Rapid Evidence 20 
Assessment (REA) was used to collate research on AM use published in peer-reviewed 21 
journals between 2000 and 2016. Forty-eight papers were identified and reviewed. The 22 
summary of findings highlights a number of issues regarding current knowledge of the 23 
use of AMs in food-producing animals and explores the attitudes of interested parties 24 
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regarding the reduction of AM use in livestock. Variation between and within countries, 25 
production types and individual farms demonstrates the complexity of the challenge 26 
involved in monitoring and regulating AM use in animal agriculture. Many factors that 27 
could influence the prevalence of AMR in livestock are of concern across all sections of 28 
the livestock industry. This REA highlights the potential role not only of farmers and 29 
veterinarians but also of other advisors, public pressure and legislation to influence 30 
change in the use of AMs in livestock. 31 
 32 
Introduction 33 
Food-producing animals throughout the world are likely to be exposed to antimicrobial 34 
(AM) treatment. Whilst AM use may vary widely between and within countries, species, 35 
production systems and individual farms (Sawant and others 2005), over the last 50 36 
years AMs have formed a key part of animal agriculture, especially in the developed 37 
world (Busani and others 2004). Yet debate is growing over the implications for human 38 
health of using AMs in food-producing animals. The crossover in AM use between 39 
human and veterinary medicine has also given rise to concerns that resistance to AMs 40 
may be spread from food-producing animals to human beings. 41 
As a response to these concerns, national and international bodies including the World 42 
Health Organisation, the World Organisation for Animal Health (OIE) and the Food and 43 
Agriculture Organisation of the United Nations have called for AMs to be used 44 
responsibly and appropriately by all those who administer them. On a national level, 45 
guidance and legislation surrounding AM use in food-producing animals varies 46 
considerably (Scott and others 2015).  47 
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In order to better understand the role that AMs currently play in human and veterinary 48 
medicine, recent calls have highlighted the need for improved monitoring of AM use, 49 
particularly in food-producing animals (Gonzalez and others 2010). Monitoring usage 50 
alone, however, reveals little about what is driving AM use in practice, such as the 51 
beliefs, motivations and activities of stakeholders involved at ground level, particularly 52 
farmers and their veterinarians. Such understanding is vital if a true assessment is to be 53 
made as to whether AMs are being used as advised (i.e. responsibly and appropriately), 54 
as well as to identify potential motivators and barriers to change in practices that may 55 
be necessary to meet these requirements.  56 
As part of a larger project, a Rapid Evidence Assessment (REA) was conducted to 57 
investigate what is currently known about the use of AMs in food-producing animals, 58 
encompassing their use at farm level, the practices and perceptions of the stakeholders 59 
involved in their administration, and the availability and validity of data on their use in 60 
practice. REAs are increasingly promoted as a valid alternative to systematic reviews of 61 
the research literature when time constraints do not allow a full systematic review to be 62 
undertaken, and are completed in full acknowledgement of the trade-off between a 63 
review being exhaustive and it being feasible to complete within a limited period of time 64 
(Ganam 2010; Thomas and others 2013). REAs allow for the comprehensive and 65 
descriptive assessment of a defined body of literature and, as Varker and others (2015) 66 
point out: ‘rigorous methods for locating, appraising and synthesizing evidence from 67 
previous studies can be upheld and results can be produced in a fraction of the time 68 
required for a full systematic review’. Moreover, REAs also ‘serve as an informative brief 69 
that prepares stakeholders for discussion on a policy issue (Varker and others 2015). 70 
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While the application of the REA methodology to more qualitative and social material is 71 
generally less common than its use in quantitative and technological review (Thomas 72 
and others 2013), the increasingly acknowledged explanatory power of qualitative 73 
evidence, and its particular relevance here in the case of the ongoing debate over AMR, 74 
make a strong case for such evidence- where robustly and convincingly generated- to 75 
be appropriately and collectively reviewed. 76 
 77 
Materials and methods 78 
The validity of the REA method is in large part dependent upon the transparency of the 79 
process employed to identify and select papers for consideration. Consequently, a 80 
comprehensive description of the overall REA methodology adopted here, time span 81 
and search strategies are reported in Figure 1 and in the Supplementary Material. 82 
Although the methodology adopted and the restricted number of scientific publications 83 
did not allow for an exhaustive appraisal of the study design and validity of every study 84 
included, this was not the purpose of the REA.  85 
 86 
Results 87 
In total, 48 peer-reviewed papers fell within the remit of addressing current practice and 88 
attitudes towards AM use in food-producing animals. Highlights of the papers identified 89 
and general overviews are presented, by species, in the text. For a comprehensive 90 
summary of the papers identified by the REA, please see Supplementary Material. 91 
 92 
Comparison of findings by production system 93 
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Pigs 94 
In some countries, the largest proportion of single-species AMs sold for food-producing 95 
animals are intended for pigs (VMD, 2014). This may result from the fact that pigs are 96 
commonly treated as a group rather than as individuals (Merle and others 2012; Sjolund 97 
and others 2015; Sjolund and others 2016; Timmerman and others 2006), although 98 
individual treatments were most common in Sweden (Sjolund and others 2016). 99 
Furthermore, it has been suggested that a shift over the last decade from in-feed to in-100 
water group treatments has led to an increase in antimicrobial use on pig farms (Fertner 101 
and others 2016). Across Belgium, France, Germany and Sweden, weaned pigs tended 102 
to have more treatments than suckling or finishing pigs (Sjolund and others 2016). 103 
 104 
AM use by class 105 
Chauvin and others (2002) noted that French pig veterinarians prescribed numerous 106 
AMs to pigs, often prescribing many for similar purposes. Overall, tetracyclines were 107 
identified as being prescribed frequently (typically for respiratory conditions), as were 108 
peptides (colistin), macrolides (both predominantly for enteric conditions), 109 
benzylpenicillins, beta-lactams, doxycycline and amoxicillin (Bashahun and Odoch 110 
2015; Chauvin and others 2002; Moreno 2012; Sjolund and others 2016; Timmerman 111 
and others 2006; van Rennings and others 2015). Fluoroquinolones and cephalosporins 112 
were either not used at all or used in low levels (Chauvin and others 2002; Sjolund and 113 
others 2015; Sjolund and others 2016; Timmerman and others 2006), and were often 114 
used as injectables administered to individual animals.  115 
 116 
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AM dosing 117 
Considerable variation in AM use was identified, with treatment durations ranging from 118 
1-21 days. The number of daily dosages (NDD) per average pig year ranged from 0-119 
400, indicating that while some farms managed to rear pigs without the use of AMs, 120 
others exceeded the defined (registered) animal daily dose for one year (Van der Fels-121 
Klerx HJ 2011). Inappropriate dosing was identified as being a common factor, with 122 
reports of 50-75% of oral AM formulations underdosed, and 41->90% of parenteral 123 
formulations overdosed (Chauvin and others 2002; Trauffler and others 2014). 124 
Vaccination is often touted as an alternative to AM use in production animals, and one 125 
paper reported vaccination rates ranging from 11-87% (Stevens, 2007). Group 126 
prophylactic or metaphylactic treatments were also common (Timmerman and others 127 
2006). Using AMs prophylactically was considered both justifiable and prudent by both 128 
veterinarians and farmers (Coyne and others 2014; Stevens 2007), although many 129 
farmers felt that the amount of AMs used for this purpose could be reduced (Stevens  130 
2007). 131 
 132 
Cattle 133 
Within the dairy sector, treatments for mastitis along with dry cow therapy administered 134 
at the end of lactation made up a large proportion of the AMs administered (Brunton and 135 
others 2012; Gonzalez Pereyra and others 2015; Higgins and others 2012; Stevens and 136 
others 2016; Swinkels and others 2015). In some countries, routine preventive use of 137 
AMs in all cows is forbidden, so AM dry cow therapy can only be used in cows with pre-138 
existing intramammary infections (Swinkels and others 2015). One study comparing 139 
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organic and conventional systems found the types of antibiotic tubes and injectables 140 
used were very similar, although while 85% of conventional farmers used dry cow tubes 141 
on all cows at drying off, only 18% of organic farmers did the same (Brunton and others 142 
2012). 143 
 144 
AM use by class 145 
Critically important AMs such as 3rd and 4th generation cephalosporins were used for 146 
mastitis extensively in the UK, Belgium and the US (Brunton and others 2012; Stevens 147 
and others 2016; Zwald and others 2004), but less so in Italy and Switzerland (Busani 148 
and others 2004; Gonzalez and others 2010; Green and others 2010). The use of beta-149 
lactams including penicillins, aminoglycosides, tetracyclines, aminocyclitols, lincomycin 150 
and trimethoprim/sulphonamide groups was reported in Argentinian, German, Swiss 151 
and American studies (Gonzalez Pereyra and others 2015; Green and others 2010; 152 
Merle and others 2012).  153 
A small number of dairy herds in two US studies reported using AM products that are 154 
either explicitly prohibited for use in dairy cattle (Zwald and others 2004) or not 155 
recommended in food-producing animals (Cattaneo and others 2009); this practice was 156 
also reported in Nigeria (Ojo and others 2016). 157 
 158 
Calf treatment 159 
Calves appear to receive more AM treatments than older animals in dairy production in 160 
Sweden and Germany (Merle and others 2012; Ortman and Svensson 2004), although 161 
lower use was reported in calves than dairy cows in Argentina (Gonzalez Pereyra and 162 
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others 2015). Fluoroquinolones were extensively used to treat enteritis in Argentina and 163 
Italy (Busani and others 2004; Gonzalez Pereyra and others 2015). A Swedish study 164 
(Ortman and Svensson 2004) found that 61% of farmers administered AM treatment 165 
without prior consultation with a veterinarian, although veterinarians became 166 
increasingly involved in treatment as the animals got older.  167 
 168 
AM dosing 169 
Treatment durations were reported to be longer for injectable preparations than for oral 170 
preparations (Ortman and Svensson 2004). Inappropriate dosing was reported, with 171 
overdosing compromising the stated withdrawal period and underdosing possibly acting 172 
as a risk factor for the development and spread of antimicrobial resistance (AMR) 173 
(Gonzalez and others 2010). Duration of mastitis treatment was occasionally or 174 
frequently extended beyond the duration initially specified (Swinkels and others 2015), 175 
and low numbers of farmers said they always completed a course of AMs presented for 176 
a given condition (Sawant and others 2005).  177 
One of the risk factors for the spread of AMR is the exposure of calves to AMs through 178 
the provision of antibiotic waste milk. Although this practice is commonplace (Brunton 179 
and others 2012; Zwald and others 2004), waste milk is not the only means by which 180 
calves may be exposed to AMs. Commercial milk substitute containing prescription 181 
antibiotics was often reported (Brunton and others 2012; Zwald and others 2004). 182 
Italian veterinarians reported often or sometimes administering AMs before the onset of 183 
clinical signs of diarrhoea (20%) and respiratory disease (28%), while 62% prescribed 184 
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AMs prophylactically against mastitis at drying off, and often reported failure of AM 185 
treatment (Busani and others 2004).  186 
 187 
Other species  188 
A study into the use of antibiotics in intensive poultry farms in Uganda found that the 189 
majority (96.7%) of study participants frequently used antibiotics in their animals and 190 
that 33.3% (n=10) used antibiotics for growth promotion, furthermore it was reported 191 
that ‘most’ of the participants admitted to selling their products within the meat 192 
withdrawal times (Bashahun and Odoch 2015). Another study assessing the usage and 193 
practices of antimicrobial use in production animals in Nigeria surveyed producers 194 
farming chicken, turkey, guinea fowl, geese, duck, horse, cattle sheep, goat, dog, rabbit 195 
and quail. This study found that AMs were widely used in all production animals, and 196 
frequently used for prophylaxis, including the use of critically important AMs for this 197 
purpose. The use of antimicrobials banned for use in humans and animals was also 198 
reported (Ojo and others 2016). 199 
 200 
Attitudes, beliefs and external influences on AM use 201 
Factors influencing farmers’ use of AMs 202 
Type of production system, high production costs and an inability to reinvest in 203 
infrastructure were identified as factors that UK veterinarians and pig farmers felt 204 
influenced their AM usage, with the implication that AMs were being relied upon in the 205 
short term (Coyne and others 2014; Stevens 2007). Farmers who reported that their 206 
farm environment could be improved were significantly more likely to use in-feed AMs 207 
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for their growers and finishers than those who did not (Stevens 2007). In the UK, farm 208 
type was found to influence in-feed AM use, and in Austrian pig herds, farm type was 209 
found to impact average AM consumption (Stevens 2007; Trauffler and others 2014). In 210 
Austria, farm size had no significant impact on AM consumption, although there was an 211 
effect of the individual veterinarian on the therapy indication and active substance 212 
chosen (Trauffler and others 2014). In Belgian pig herds, a negative association was 213 
identified between biosecurity score and treatment incidence (based on used daily 214 
dose); fewer prophylactic AM group treatments were given in herds with higher 215 
biosecurity (Laanen and others 2013). Farmers in Nigeria also acknowledged that 216 
readily available AMs may encourage non-adherence to hygienic principles and 217 
management (Ojo and others 2016).  218 
In beef cattle, herd size and farm type (cow-calf only or multiple operation type) had an 219 
influence on AM use (Green and others 2010).  220 
A survey of dairy farmers in England and Wales found that only 17% of farmers would 221 
ask for veterinary advice before administering antibiotics to their animals (Jones and 222 
others 2015). In Ohio, over three-quarters (77%) of dairy veterinarians surveyed 223 
believed their clients followed protocols for AM use, while only 23% stated that they 224 
supplied protocols for AM use every time they prescribed them (Cattaneo and others 225 
2009). Veterinarians in an Ohio-based survey also believed that their clients frequently 226 
used AMs without veterinary consultation (Cattaneo and others 2009). Similar findings 227 
were reported for Pennsylvania dairy farmers (Sawant and others 2005) as well as 228 
Nigerian farmers (Ojo and others 2016). Farmer AM treatment threshold was, however 229 
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found to have no correlation with the use of protocols or frequency of veterinary visits in 230 
US farmers from Michigan and Ohio (Habing and others 2016). 231 
Owners and managers of US feedlots perceived the expectations of many other 232 
members of the feedlot network (packers, retailers, consumers) to be important 233 
considerations in their own decision-making regarding AM use and also reported having 234 
a moral obligation to the cattle to treat with AMs, but degree of this perceived obligation 235 
varied by circumstance (McIntosh and Dean 2015). Concern for the public health impact 236 
due to AM use in livestock seemed to affect AM use of farmers from Ohio and Michigan, 237 
US, as those with more concern about this had a significantly higher treatment threshold 238 
in their animals (Habing and others 2016). 239 
Extending treatment duration for clinical mastitis was found to be a social norm among 240 
farmers in the Netherlands and Germany (Swinkels and others 2015). In addition, some 241 
farmers reported extending treatment because it made them feel like ‘good farmers’ 242 
(Swinkels and others 2015). Danish organic dairy farmers also tended to perceive AMs 243 
as the treatment method with the best prognosis as well as the most responsible 244 
method to aid animal welfare and end animal suffering (Vaarst and others 2003). 245 
 246 
Farmers’ knowledge of correct AM use 247 
Just over half (53%) of 71 English and Welsh dairy farmers responding to a survey, 248 
reported knowledge of the Responsible Use of Medicines in Agriculture Alliance’s 249 
(RUMA) guidelines for use of AMs in cattle production in the UK, and 30% were not 250 
aware of concerns over the use of 3rd and 4th generation cephalosporins (Jones and 251 
others 2015). Furthermore, 20% of these farmers admitted that they do not always 252 
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complete a full course of AMs as prescribed (Jones and others 2015). Spanish farmers 253 
are also “not very knowledgeable” about the proper use of AMs, and some may not be 254 
clear about the differences between curative and preventive uses (Moreno 2014). 255 
Approximately half (14/30) of  Ugandan farmers were not aware of withdrawal periods 256 
for antibiotics (Bashahun and Odoch 2015).  Farmers from various European countries 257 
tended to think they used AMs more judiciously and less frequently than their peers 258 
(Coyne and others 2014; Visschers and others 2015).  259 
One study identified ‘learning processes’ that farmers used to implement new health 260 
practices, along with the role of the veterinarian and other technical advisors who 261 
facilitated farmers to implement change by aiding these learning processes (Fortane 262 
and others 2015). 263 
 264 
Farmers’ motivation for AM use and reduction 265 
Just over 70% of surveyed dairy farmers from England and Wales agreed that reducing 266 
AM use in their herd over the next year would be a good thing, with 59% stating that 267 
they had the skills and knowledge to do so (Jones and others 2015). Restricting AM use 268 
was also considered important by 87% of Dutch dairy farmers (Scherpenzeel and others 269 
2016) . Both the UK and Dutch farmers as well as farmers from Belgium, France, 270 
Germany, Sweden and Switzerland cited a reduced cost of production as the primary 271 
reason driving them to reduce AM use (Brunton and others 2012; Jones and others 272 
2015; Scherpenzeel and others 2016; Visschers and others 2015). Dutch farmers also 273 
cited ‘improving public health’ as one of the most positive outcomes of restricting AM 274 
use (Scherpenzeel and others 2016). French pig farmers cited various reasons for 275 
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choosing to reduce AM use, including health events, new economic and health 276 
strategies and ethical considerations (Fortane and others 2015).  277 
 278 
Farmer concerns regarding AM reduction  279 
Over half (53%) of British pig farmers believed that AM use resulted in the production of 280 
increased amounts and cheaper food, and 21% indicated the use of AMs for growth 281 
promotion was justified (Stevens 2007). A minority (18%) of English and Welsh dairy 282 
farmers, however, thought that milk production would decline if they reduced AM use in 283 
their herds (Jones and others 2015). Spanish farmers also agreed that AMs play a role 284 
in enhancing performance parameters (Moreno 2014). Dutch dairy farmers cited 285 
uncertainty over recovery of sick cows and the number of sick cows as concerns 286 
regarding reduced AM use as well as additional labour requirements and feeling that 287 
they were being pushed to follow rules they do not agree with (Scherpenzeel and others 288 
2016). In this same study, Dutch farmers implementing selective dry cow therapy 289 
considered ‘financial consequences’ a negative impact of reduced AM use less often 290 
than those using blanket dry cow therapy (Scherpenzeel and others 2016). 291 
 292 
Farmer attitudes towards AMR  293 
The threat of AMR was typically underplayed by food-producing animal stakeholders 294 
(Moreno 2014), with it being felt that there was insufficient evidence to decisively prove 295 
the link between using AMs in food-producing animals and the development of AMR in 296 
pathogens infecting humans (Coyne and others 2014). Most farmers from South 297 
Carolina that participated in one study seemed unconcerned that AM use in animals 298 
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could lead to resistance among farm workers (Friedman and others 2007), while 58% of 299 
conventional farmers from Ohio and Michigan, US, disagreed that antibiotic use in 300 
agriculture led to resistant bacterial infections in people. In the UK, 7% of organic 301 
farmers felt similarly (Habing and others 2016). UK farmers were uncertain as to 302 
whether reduced AM use on their farms would affect animal health and welfare or 303 
whether such a decrease would reduce AMR (Jones and others 2015). 304 
 305 
Veterinarian attitudes towards AMR 306 
In the UK, veterinarians were cited as farmers’ most trusted information source (Jones 307 
and others 2015). The majority of Dutch and Flemish veterinarians responding to a 308 
survey reported to have become more aware of the need to restrict the use of AMs and 309 
were aiming to reduce AM use in their practice as far as possible (Postma and others 310 
2016). In the US, however, a negative correlation between the number of years a US 311 
veterinarian had been in practice and their knowledge of AMR was identified (Cattaneo 312 
and others 2009). Furthermore, years qualified was associated with veterinarians being 313 
less concerned about AMR (Speksnijder and others 2015a) and more confident in their 314 
independent prescribing practice (Dean 2011). Ohio dairy veterinarians were more likely 315 
to agree that AMR will negatively affect animal health (86%) than human health (63%; 316 
Cattaneo and others 2009). Key information sources for prescribing AMs were reported 317 
by veterinarians to be other veterinarians, their own personal experience, the label or 318 
leaflet accompanying the product, training or literature with which they were familiar, 319 
previous experience or the results of culture and sensitivity testing (De Briyne and 320 
others 2013; Dean 2011; Gibbons and others 2013; Postma and others 2016).  321 
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 322 
Veterinarian motivation for prescribing 323 
Veterinarians in the UK, Ireland, the Netherlands and Belgium reported that demands 324 
from farmers, advisors or other veterinarians did influence their prescribing; they also 325 
felt under more pressure from legislation and public perception than farmers reported 326 
(Coyne and others 2014; Gibbons and others 2013; Postma and others 2016; 327 
Speksnijder and others 2015b). Dutch and Flemish veterinarians reported to have little 328 
concern over the farmers’ preference for AM product when prescribing (Postma and 329 
others 2016). Social pressure from other feedlot veterinarians and nutritionists, 330 
however, was found to have more of an influence on beef feedlot cattle veterinarian 331 
attitudes towards AMs; these veterinarians cited their highest perceived expectation for 332 
AM prescription was from pharmaceutical companies (Jan 2010). Their levels of trust in 333 
other relevant actors (government agencies, other veterinarians, etc.) also influenced 334 
their decision making (Dean 2011). A sense of moral obligation to the public was found 335 
to be associated with a negative attitude to prescribing AMs (McIntosh and others 336 
2009). The influence of these factors varied in different clinical situations, and social 337 
pressure (particularly that of colleagues and co-workers compared to, for example, 338 
nutritionists or clients) had more of an influence (Jan 2010). No evidence was found that 339 
veterinarians prescribing habits were driven by revenue or profit margin (De Briyne and 340 
others 2013; Gibbons and others 2013; Postma and others 2016), and preserving the 341 
veterinary pharmacy for future years was found to be a strong motivator for Dutch and 342 
Flemish veterinarians to reduce AM use (Postma and others 2016).  343 
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In the Netherlands, benchmarking that made the prescription patterns of veterinarians 344 
transparent was introduced in the hope of shifting social norms and encouraging 345 
veterinarians to self-regulate AM use (Bos and others 2015).  346 
 347 
Sensitivity testing 348 
The use of sensitivity testing varied widely between the European countries surveyed, 349 
with veterinarians reporting their decision whether to test depended on the animal’s 350 
response to initial therapy as well as the veterinarian’s knowledge of that animal or farm 351 
(De Briyne and others 2013). More rapid results and cheaper sensitivity testing were 352 
described to be key factors that would encourage veterinarians to make more use of 353 
sensitivity testing (De Briyne and others 2013). 354 
 355 
Quality of data on AM use 356 
It is challenging to measure on-farm AM usage due to the difficulty in obtaining an 357 
accurate account of the dosage and duration of treatment, with farmers often relying on 358 
their memory alone for recalling past treatments (Zwald and others 2004) and often 359 
under-reporting medicine use (Redding and others 2014). Veterinary records have been 360 
found to be more accurate than those of farmers, although both were reported to be 361 
incomplete or implausible (Gonzalez and others 2010; Merle and others 2012; Trauffler 362 
and others 2014). Data from the VETSTAT system in Denmark indicated that most of 363 
the entries from pharmacies were correct, while there were a high percent of errors in 364 
data originating from veterinarians and feed mills (Stege and others 2003).  365 
 366 
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Discussion 367 
The 48 papers identified by the REA and summarised above highlight a number of 368 
issues regarding current drivers for the future use of AMs in food-producing animals. 369 
Table 1 summarises the key drivers of current antimicrobial use and the identified 370 
barriers for change, as taken from the REA. In terms of barriers to change, these 371 
summary findings reveal what can be interpreted as a sense of inflexibility particularly in 372 
the organisation of production systems and, as a consequence, in the potential ‘spaces’ 373 
for change, but also, though arguably to a lesser extent, in producer sensibilities around 374 
the nature of good husbandry. There is also, however, a clear indication that amongst 375 
respondents to the various surveys reviewed, there is both an awareness of the issue 376 
and a willingness to explore the potentials for change in antimicrobial use. 377 
The huge variation between and within countries, production types and individual farms 378 
demonstrates the complexity of the challenge involved in monitoring and regulating AM 379 
use in animal agriculture.  380 
Table 1. Identified key drivers and barriers to change of antimicrobial use in food-381 
producing animals 382 
Identified drivers in reducing antimicrobial use 
Higher levels of on-farm biosecurity lead to lower prophylactic use 
New methods of knowledge exchange and learning improve farmer awareness of and response to 
more sensible antimicrobial use 
Reducing costs of production would encourage reduced antimicrobial use 
Farmers recognise and acknowledge the need to reduce antimicrobials 
Veterinarians in general support antimicrobial use reduction 
No evidence exists that medicine sales by veterinarians are a factor driving overuse of antimicrobials 
Better diagnostics or wider use of diagnostics would improve the ability to use medicines more 
effectively 
Wider use of vaccines to prevent disease would reduce antimicrobial use 
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Identified barriers to more sustainable use 
Production system inflexibility hinders reduction in antimicrobial use 
High production costs reduce capacity for antimicrobial use reduction 
Low capacity for reinvestment in farm buildings reduces capacity for reduction in antimicrobial use 
Farmer concern over being a ‘good’ farmer hinders reduces antimicrobial use 
Farmer concern for welfare and health of animals leads to a reluctance to reduce antimicrobial use 
Farmer failure to follow treatment guidelines leads to over- or under-dosing of antimicrobials 
Farmer belief that antimicrobial use will improve profitability hinders reduction in antimicrobial use 
Veterinarians are under pressure from farmers, feed suppliers and others to use antimicrobials 
Changes in antimicrobial use in feed regimes (e.g. from feed to water) represents potential for 
increased antimicrobial use 
Farmers initiating treatment without seeking veterinary advice leads to inappropriate use of 
antimicrobials 
Some farmers and veterinarians believe that antimicrobial prophylaxis is justifiable and prudent 
 383 
The sample sizes and associated response rates in these studies illustrates the 384 
difficulties in recruiting participants for AM research, and should be taken into account 385 
when interpreting results. Other challenges include concerns about the ease of 386 
comparing the findings of studies across methodologies, countries and production 387 
systems. While some papers report AM product names, others use classes or active 388 
substances to categorise AMs. Complexity increases when the amount of AMs used is 389 
considered. A document published by the European Medicines Agency in 2015 set out 390 
principles for the calculation of defined daily dose for animals (DDDvet) and defined 391 
course dose for animals (DCDvet) as a veterinary equivalent to the defined daily dose 392 
developed for human medicine, taking medicine potency into account (EMA 2015). 393 
These methods are not globally recognised, however, and there remains a variety of 394 
different usage measures or dosage calculations included in the literature (Gonzalez 395 
and others 2010; Moreno 2012; Taverne 2015; Timmerman and others 2006).  396 
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Over half of the papers included in this REA reported research conducted within the EU. 397 
This may reflect the greater regulation of AM use in this region compared to other parts 398 
of the world (Scott and others 2015). The research question addressed by this REA 399 
focused particularly on pigs, poultry and cattle, yet only two papers on AM use in poultry 400 
could be identified for inclusion, suggesting a deficit of published peer-reviewed 401 
research in the poultry sector. The majority of papers identified in this REA instead 402 
covered AM use in pigs and cattle. Only one study performed within the EU made 403 
reference to AM use by a food-producing animal other than pigs and cattle, highlighting 404 
the impact of a few prescriptions for quinolones used in aquaculture on kilograms of 405 
AMs distributed per month by Danish pharmacies, due to the quantities prescribed 406 
(Stege and others 2003). Given the expanding global aquaculture industry, research 407 
into current AM use and beliefs in this sector should also be a priority. 408 
There are a number of limitations of conducting an REA rather than an exhaustive 409 
systematic review, including biases relating to publication, language and accessibility, 410 
although these are not unique to REAs (Thomas and others 2013). Nonetheless, this 411 
work demonstrates the valuable contribution of the REA methodology to research when 412 
rapid insight into the current status of research in a given area is needed. 413 
 414 
Conclusions 415 
Multiple factors which could influence the prevalence of AMR in livestock species - 416 
including the improper use of AMs in both the pig and cattle sectors, across all global 417 
regions - remain a concern. Prophylactic and metaphylactic use of AMs appears to be 418 
common practice across all sectors for which relevant literature was found, largely pig 419 
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and cattle production within EU countries, but also other sectors worldwide. Literature 420 
regarding the use of AMs in poultry production in the EU in particular was lacking from 421 
the searches. It is likely that data regarding AM consumption in poultry production are 422 
collected by poultry producers in some countries but these data are not available in the 423 
published literature. Work should therefore be done to amalgamate and publish any 424 
existing data or investigate this area of AM use further. Levels of farmer knowledge with 425 
regard to proper and prudent use of AMs varies between groups, although veterinary 426 
input regarding the treatment of animals was, on the whole, low across all geographical 427 
locations.   428 
Economic concerns and restraints relating to farm infrastructure or production type may 429 
limit farmers’ ability or motivation to alter AM use in their animals. Veterinary advice, 430 
public pressures, input from other advisors and moral obligation influence farmers’ 431 
attitudes to AM use. Similarly, veterinary prescribing habits have been shown to be 432 
influenced by similar factors to differing degrees, and veterinarians’ confidence in their 433 
own knowledge of the AMs they are prescribing also influence prescribing behaviour. It 434 
would stand to reason, therefore, that increasing knowledge of the proper use of AMs 435 
as well as awareness of AMR and encouraging a reduction in AM use in all of these 436 
sectors is necessary, and this could have synergistic effects when compared to 437 
strategies targeting only one group of actors.  438 
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